From January 9 to 11, 2023, Dr. Vince Gao, CEO of Govita, was invited to attend the 12th World Gene Convention in Japan. During the conference, Dr. Gao presented Govita’s latest research on “Correlating genotype and phenotype data to generate personalized solutions to improve long coventry symptoms”. The research results have received the attention of the world’s academic experts, especially a professor from Harvard Medical School. Govita will continue to focus on the development and analysis of molecular biomarkers, associating test data with individual phenotypes, with clinicians as partners providing personalized interventions to improve health, delay aging and enhance overall quality of life.
